{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:10:19Z","timestamp":1779095419827,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"am","delay-in-days":337,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA142543"],"award-info":[{"award-number":["P30CA142543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210130"],"award-info":[{"award-number":["RP210130"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.diabres.2026.113119","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:46:46Z","timestamp":1769442406000},"page":"113119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["GLP-1 RA initiation versus metformin and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-4127","authenticated-orcid":false,"given":"Jes\u00fas Gibran","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6104-0156","authenticated-orcid":false,"given":"Omer","family":"Abdelgadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2312-8449","authenticated-orcid":false,"given":"Maryam R.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime P.","family":"Almandoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5377-9167","authenticated-orcid":false,"given":"Carlos H.","family":"Barcenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay G.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Messiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113119_b0005","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.3390\/ijms25095027","article-title":"Pathophysiology and advances in the therapy of cardiomyopathy in patients with diabetes mellitus","volume":"25","author":"Graczyk","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113119_b0010","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.3390\/ijms25137476","article-title":"Associations between diabetes mellitus and selected cancers","volume":"25","author":"Pliszka","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113119_b0015","article-title":"Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: beyond ischemia with non-obstructive coronary arteries (INOCA)","volume":"40","author":"Kreidieh","year":"2024","journal-title":"Am Heart J Plus"},{"key":"10.1016\/j.diabres.2026.113119_b0020","article-title":"Doxorubicin-induced cardiotoxicity and risk factors","volume":"50","author":"Belger","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.diabres.2026.113119_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115170","article-title":"Glucagon-like peptide-1 agonists reduce cardiovascular events in cancer patients on immune checkpoint inhibitors","volume":"216","author":"Chiang","year":"2025","journal-title":"Eur J Cancer"},{"issue":"16 suppl","key":"10.1016\/j.diabres.2026.113119_b0030","doi-asserted-by":"crossref","first-page":"12026","DOI":"10.1200\/JCO.2024.42.16_suppl.12026","article-title":"Impact of glucagon-like peptide-1 agonists on anthracycline- or HER2 inhibitor\u2013associated cardiotoxicity in patients with breast cancer and diabetes mellitus","volume":"42","author":"Chang","year":"2024","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.diabres.2026.113119_b0035","doi-asserted-by":"crossref","first-page":"11299","DOI":"10.3390\/ijms252011299","article-title":"Glucagon-like peptide-1 receptor agonists in cardio-oncology: pathophysiology of cardiometabolic outcomes in cancer patients","volume":"25","author":"Quagliariello","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.diabres.2026.113119_b0040","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/jcm14082705","article-title":"The potential role of GLP-1 receptor agonists against anticancer-drug cardiotoxicity: a scoping review","volume":"14","author":"Biondi","year":"2025","journal-title":"J Clin Med"},{"issue":"15","key":"10.1016\/j.diabres.2026.113119_b0045","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2174\/0109298673320425240806051215","article-title":"Unveiling the protective role of metformin against chemotherapy-induced cardiotoxicity: a comprehensive scoping review on non-clinical studies","volume":"32","author":"Rahimifard","year":"2025","journal-title":"Curr Med Chem"},{"issue":"7","key":"10.1016\/j.diabres.2026.113119_b0050","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. a consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.diabres.2026.113119_b0055","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2026.113119_b0060","unstructured":"TriNetX. Data analytics: real-world datasets [Internet]. Cambridge (MA): TriNetX; c2024 [cited 2026 Jan 14]. Available from: https:\/\/www.trinetx.com\/solutions\/real-world-datasets\/."},{"issue":"3","key":"10.1016\/j.diabres.2026.113119_b0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"25","key":"10.1016\/j.diabres.2026.113119_b0070","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.diabres.2026.113119_b0075","article-title":"Long-term cardiovascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a systematic review","volume":"16","author":"Tariq","year":"2024","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.diabres.2026.113119_b0080","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cardfail.2025.01.022","article-title":"Efficacy of GLP-1 receptor agonists in patients with heart failure and mildly reduced or preserved ejection fraction: a systematic review and meta-analysis","volume":"31","author":"Waqas","year":"2025","journal-title":"J Card Fail"},{"issue":"41","key":"10.1016\/j.diabres.2026.113119_b0085","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.diabres.2026.113119_b0090","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2026.113119_b0095","doi-asserted-by":"crossref","DOI":"10.1177\/0300060521992981","article-title":"GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting NF-\u03baB signalling","volume":"49","author":"Chen","year":"2021","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.diabres.2026.113119_b0100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2026.113119_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123912","article-title":"Liraglutide attenuates doxorubicin-induced cardiomyocyte ferroptosis via DHHC7-mediated STAT3 palmitoylation","volume":"379","author":"Gao","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.diabres.2026.113119_b0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.cbi.2019.03.012","article-title":"Exenatide alleviates adriamycin-induced heart dysfunction in mice: modulation of oxidative stress, apoptosis and inflammation","volume":"304","author":"Fang","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.diabres.2026.113119_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13293-016-0059-9","article-title":"Sex and estrogens alter the action of glucagon-like peptide-1 on reward","volume":"7","author":"Richard","year":"2016","journal-title":"Biol Sex Differ"},{"issue":"Pt A","key":"10.1016\/j.diabres.2026.113119_b0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2016.07.039","article-title":"GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight","volume":"110","author":"Vogel","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.diabres.2026.113119_b0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1074248420968689","article-title":"Age-related considerations in cardio-oncology","volume":"26","author":"Screever","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.diabres.2026.113119_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102727","article-title":"Prevention of cardiovascular disease for healthy aging and longevity: a new scoring system and related mechanisms-hallmarks-biomarkers","volume":"107","author":"Hu","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.diabres.2026.113119_b0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13659-024-00432-4","article-title":"Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease","volume":"14","author":"Hu","year":"2024","journal-title":"Nat Prod Bioprospect"},{"issue":"9","key":"10.1016\/j.diabres.2026.113119_b0140","first-page":"1319","article-title":"Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications","volume":"6","author":"Hu","year":"2014","journal-title":"J Thorac Dis"},{"issue":"8","key":"10.1016\/j.diabres.2026.113119_b0145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.0000000000000152","article-title":"Target trial emulation to improve causal inference from observational data: what, why, and how?","volume":"34","author":"Fu","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113119_b0150","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113119_b0155","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:41:15Z","timestamp":1779093675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"alternative-id":["S0168822726000380"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113119","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 RA initiation versus metformin and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113119"}}